Clinical Rheumatology

, Volume 37, Issue 4, pp 1025–1026 | Cite as

Correction to: ADAM-17 is expressed in the inflammatory myopathy and is involved with interstitial lung disease

  • Airi Nishimi
  • Takeo Isozaki
  • Shinichiro Nishimi
  • Sho Ishii
  • Takahiro Tokunaga
  • Hidekazu Furuya
  • Kuninobu Wakabayashi
  • Tsuyoshi Kasama
Correction

Correction to: Clinical Rheumatology

  https://doi.org/10.1007/s10067-018-4014-5

The original version of this article, unfortunately, contained errors and are now presented correctly in this article.

In the “Result” section under subtitle “ADAM-17 expression on inflammatory myopathy tissues” citation for “(Fig. 1a, b)” should have read as “(Fig. 1A, d)” and under the subtitle “Clinical characteristics of study subjects”, the line “CK and lactate dehydrogenase (LDH)” should have read as “KL-6”.

Figure 1 caption and the panel C image of the figure were also corrected as shown below:
Fig. 1

ADAM-17 is expressed on the muscle tissue of an inflammatory myopathy patient. ad Representative photomicrographs of muscle tissue samples from patients with inflammatory myopathy. a and c Cryosections were stained for ADAM-17. ADAM-17 expression on inflammatory cells (circle and arrow). a Original magnification, × 100. c Original magnification, × 400. b and d Cryosections were stained for control IgG. b Original magnification, × 100. d Original magnification, × 400

Copyright information

© International League of Associations for Rheumatology (ILAR) 2018

Authors and Affiliations

  • Airi Nishimi
    • 1
  • Takeo Isozaki
    • 1
  • Shinichiro Nishimi
    • 1
  • Sho Ishii
    • 1
  • Takahiro Tokunaga
    • 1
  • Hidekazu Furuya
    • 1
  • Kuninobu Wakabayashi
    • 1
  • Tsuyoshi Kasama
    • 1
  1. 1.Division of Rheumatology, Department of MedicineShowa University School of MedicineTokyoJapan

Personalised recommendations